Research Article
Clinical Features of Acute Anterior Uveitis with Complicated Course in a Slovenian Patient Population
Table 2
Clinical features, ocular complications, investigations performed in patients and treatment choices.
| Variable | HLA+ | HLA− | Odds ratio | Confidence interval | value | Percentage | Number (out of 27) | Percentage | Number (out of 10) | With Haldane–Anscombe correction | Upper bound | Lower bound | Using Fisher's exact test |
| Clinical features | Fibrin exudation | 63% | 17 | 0% | 0 | 35.0 | 1.9 | 661.0 | 0.001 | Hypopyon | 23% | 6 (out of 26) | 0% | 0 | 6.7 | 0.3 | 129.9 | 0.157 | Posterior synechiae | 74% | 20 | 50% | 5 | 2.7 | 0.6 | 11.6 | 0.240 |
| Ocular complications | Cataract formation | 30% | 8 | 40% | 4 | 0.6 | 0.2 | 2.7 | 0.696 | Cystoid macular edema | 8% | 2 (out of 26) | 20% | 2 | 0.4 | 0.1 | 2.4 | 0.353 | Ocular hypertension | 15% | 4 | 40% | 4 | 0.3 | 0.1 | 1.3 | 0.174 | Secondary glaucoma | 4% | 1 | 10% | 1 | 0.4 | 0.0 | 3.9 | 0.473 |
| Investigations performed in patients | Macular OCT | 67% | 18 | 60% | 6 | 1.4 | 0.3 | 5.7 | 0.716 | Aqueous humor tap | 30% | 8 | 30% | 3 | 0.9 | 0.2 | 4.2 | 1.000 | Sacroiliac joint X-ray | 22% | 6 | 30% | 3 | 0.7 | 0.1 | 3.0 | 0.679 | Serology (Treponema, Borrelia) | 26% | 7 | 30% | 3 | 0.8 | 0.2 | 3.6 | 1.000 | QuantiFERON-TB | 22% | 6 | 20% | 2 | 1.0 | 0.2 | 5.4 | 1.000 | Aerum angiotensin converting enzyme | 4% | 1 | 0% | 0 | 1.2 | 0.0 | 31.6 | 1.000 | Other ocular imaging (FA, ICG, and US) | 11% | 3 | 40% | 4 | 0.2 | 0.0 | 1.1 | 0.069 |
| Treatment choices | Topical corticosteroids | 1 | 27 | 1 | 10 | 2.6 | 0.1 | 140.7 | 1.000 | Topical mydriatics | 1 | 27 | 1 | 10 | 2.6 | 0.1 | 140.7 | 1.000 | Periocular corticosteroids | 11% | 3 | 10% | 1 | 0.9 | 0.1 | 7.1 | 1.000 | Systemic corticosteroids | 4% | 1 | 10% | 1 | 0.4 | 0.0 | 3.9 | 0.473 | Methotrexate | 26% | 7 | 10% | 1 | 2.3 | 0.3 | 15.2 | 0.404 | NSAID | 4% | 1 | 0% | 0 | 1.2 | 0.0 | 31.6 | 1.000 | Biologics | 11% | 3 | 0% | 0 | 3.0 | 0.1 | 63.4 | 0.548 |
|
|